United States · FDA National Drug Code directory
NULOJIX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0003-0371_9057087d-7e59-4e5a-8e4a-96a532efb0ab
- Product NDC
- 0003-0371
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- BELATACEPT
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20110615
- Source listing expiry
- 20261231
Source-listed ingredients
- BELATACEPT — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (0003-0371-13) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE · 0003-0371-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →